Finance

Lists
033780:KRX
KT&G Corp
195 100,00 KRW
+0,57%
(+1 100,00) 1D
21-окт., 11:17:35 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 033780...
Open
193 800 KRW
High
196 400 KRW
Low
193 500 KRW
Mkt. cap
20,25 трлн
Avg. vol.
228,97 миң
Volume
61,82 миң
Dividend
3,38%
Quarterly dividend
1 650 KRW
Ex-dividend date
2026-ж., 20-авг.
P/E ratio
14,25
52-wk high
196 400 KRW
52-wk low
132 100 KRW
EPS
13 688 KRW
Shares outstanding
103,81 млн
No. of employees
4 миң
Open
193 800 KRW
High
196 400 KRW
Low
193 500 KRW
Mkt. cap
20,25 трлн
Avg. vol.
228,97 миң
Volume
61,82 миң
Dividend
3,38%
Quarterly dividend
1 650 KRW
Ex-dividend date
2026-ж., 20-авг.
P/E ratio
14,25
52-wk high
196 400 KRW
52-wk low
132 100 KRW
EPS
13 688 KRW
Shares outstanding
103,81 млн
No. of employees
4 миң
News stories
From web sources and news partners
Profile
KT&G Corporation, originally Korea Tobacco & Ginseng, also branded as Korea Tomorrow & Global, is the leading tobacco company in South Korea with annual sales over US$4 billion. KT&G was originally a government-owned monopoly but was privatised and today is publicly traded, competing for market share with other international tobacco firms such as Philip Morris International, British American Tobacco, and Japan Tobacco. KT&G's sales volume share was 62% of the Korean market in 2009. KT&G also owns significant subsidiaries such as Korea Ginseng Corporation, Yungjin Pharm, and several bio ventures. Its headquarters are in Daejeon. Wikipedia
About KT&G Corp
CEOKyung-man Bang
Employees4,08 миң
Founded1987-ж., 1-апр.
HeadquartersТэджон, Daedeok-gu, Түштүк Корея
SectorTobacco
Websitektng.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
1,83 трлн
1,71 трлн
1,70 трлн
1,70 трлн
Cost of goods sold
933,01 млд
980,72 млд
887,77 млд
846,12 млд
Cost of revenue
933,01 млд
980,72 млд
887,77 млд
846,12 млд
Research and development expenses
18,46 млд
22,29 млд
15,58 млд
21,34 млд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
385,48 млд
435,33 млд
397,43 млд
372,14 млд
Operating expense
428,60 млд
490,15 млд
451,29 млд
440,98 млд
Total operating expenses
1,36 трлн
1,47 трлн
1,34 трлн
1,29 трлн
Operating income
465,29 млд
242,94 млд
364,54 млд
414,45 млд
Other non operating income
-27,26 млд
-33,53 млд
-24,40 млд
-20,08 млд
EBT including unusual items
544,23 млд
384,68 млд
508,31 млд
488,92 млд
EBT excluding unusual items
544,76 млд
312,85 млд
501,46 млд
486,36 млд
Income tax expense
128,56 млд
102,43 млд
129,76 млд
126,81 млд
Effective tax rate
23,62%
26,63%
25,53%
25,94%
Other operating expenses
735,00 млн
4,59 млд
4,58 млд
23,28 млд
Net income
419,25 млд
271,88 млд
380,54 млд
364,27 млд
Net profit margin
22,95%
15,86%
22,34%
21,41%
Earnings per share
3,87 миң
2,66 миң
-
-
Interest and investment income
31,06 млд
33,73 млд
28,24 млд
32,07 млд
Interest expense
-20,20 млд
-23,10 млд
-20,39 млд
-23,08 млд
Net interest expenses
10,86 млд
10,63 млд
7,85 млд
8,99 млд
Depreciation and amortization charges
18,28 млд
17,66 млд
19,97 млд
20,55 млд
EBITDA
540,52 млд
320,53 млд
442,66 млд
494,41 млд
Gain or loss from assets sale
1,26 млд
-224,18 млд
-6,72 млд
362,00 млн
AI content may include mistakes. Learn more
Google колдонмолору